Gary R. Point

988 total citations
6 papers, 767 citations indexed

About

Gary R. Point is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Gary R. Point has authored 6 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Immunology and 1 paper in Surgery. Recurrent topics in Gary R. Point's work include Immune Cell Function and Interaction (4 papers), CAR-T cell therapy research (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Gary R. Point is often cited by papers focused on Immune Cell Function and Interaction (4 papers), CAR-T cell therapy research (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Gary R. Point collaborates with scholars based in United States. Gary R. Point's co-authors include N. Joseph Espat, Mitchell Thorn, Steven C. Katz, Richard P. Junghans, Rachel A. Burga, Prajna Guha, Qiangzhong Ma, Elise McCormack, Robin Davies and Brian F. Stainken and has published in prestigious journals such as Clinical Cancer Research, Journal of Leukocyte Biology and ACS Chemical Biology.

In The Last Decade

Gary R. Point

6 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary R. Point United States 5 622 286 202 177 130 6 767
Mauro P. Avanzi United States 13 491 0.8× 156 0.5× 149 0.7× 154 0.9× 184 1.4× 22 684
Zhenlong Ye China 13 593 1.0× 342 1.2× 171 0.8× 162 0.9× 330 2.5× 19 909
Qiting Wu China 13 573 0.9× 323 1.1× 173 0.9× 141 0.8× 203 1.6× 26 745
Konstantin Dobrenkov United States 15 559 0.9× 363 1.3× 131 0.6× 190 1.1× 235 1.8× 28 829
Parisa Malekzadeh United States 7 651 1.0× 377 1.3× 150 0.7× 101 0.6× 196 1.5× 14 795
Huiping Gao China 12 616 1.0× 392 1.4× 142 0.7× 90 0.5× 248 1.9× 22 889
Chuang Sun United States 15 870 1.4× 390 1.4× 329 1.6× 232 1.3× 389 3.0× 18 1.1k
Yunxin Lai China 9 504 0.8× 250 0.9× 175 0.9× 101 0.6× 227 1.7× 10 779
Xinyue Wang China 14 538 0.9× 233 0.8× 167 0.8× 94 0.5× 184 1.4× 40 759
Astero Klampatsa United States 13 500 0.8× 220 0.8× 156 0.8× 95 0.5× 147 1.1× 17 651

Countries citing papers authored by Gary R. Point

Since Specialization
Citations

This map shows the geographic impact of Gary R. Point's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary R. Point with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary R. Point more than expected).

Fields of papers citing papers by Gary R. Point

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary R. Point. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary R. Point. The network helps show where Gary R. Point may publish in the future.

Co-authorship network of co-authors of Gary R. Point

This figure shows the co-authorship network connecting the top 25 collaborators of Gary R. Point. A scholar is included among the top collaborators of Gary R. Point based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary R. Point. Gary R. Point is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Hwang, Seo‐Kyoung, et al.. (2021). Novel in vivo and ex vivo hybrid in vivo imaging system (IVIS) imaging offers a convenient and precise way to measure the glomerular filtration rate in conscious mice. Journal of Pharmacological and Toxicological Methods. 110. 107084–107084. 3 indexed citations
2.
Xu, Hua, Michael I. Jesson, Uthpala Seneviratne, et al.. (2019). PF-06651600, a Dual JAK3/TEC Family Kinase Inhibitor. ACS Chemical Biology. 14(6). 1235–1242. 112 indexed citations
3.
Katz, Steven C., Gary R. Point, Marissa Cunetta, et al.. (2016). Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery. Cancer Gene Therapy. 23(5). 142–148. 137 indexed citations
4.
Katz, Steven C., Rachel A. Burga, Elise McCormack, et al.. (2015). Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA+ Liver Metastases. Clinical Cancer Research. 21(14). 3149–3159. 314 indexed citations
5.
Burga, Rachel A., Mitchell Thorn, Gary R. Point, et al.. (2015). Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T. Cancer Immunology Immunotherapy. 64(7). 817–829. 186 indexed citations
6.
Thorn, Mitchell, Gary R. Point, Rachel A. Burga, et al.. (2014). Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr-1+CD11b+ myeloid cells. Journal of Leukocyte Biology. 96(5). 883–894. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026